ホーム / コンテンツ / オンデマンド・ウェビナー / IQ WG Evaluation of PBPK Models for Organ-Impaired Populations
IQ WG Evaluation of PBPK Models for Organ-Impaired Populations
オンデマンド・ウェビナー

• The predictive performance of physiologically based pharmacokinetic(s) (PBPK) models for PK in renal impairment (RI) and hepatic impairment (HI) populations was evaluated using clinical data from 29 compounds with 106 organ impairment study arms were collected from 19 member companies of the International Consortium for Innovation and Quality in Pharmaceutical Development. Fifty RI and 56 HI study arms with varying degrees of organ insufficiency along with control populations were evaluated.

• Inaccuracies, typically overestimation of AUC ratios, occurred more in moderate and severe HI.

• PBPK predictions can help determine the need and timing of organ impairment study. It may be suitable for predicting the impact of RI on PK of drugs predominantly cleared by metabolism with varying contribution of renal clearance. PBPK modeling may be used to support mild impairment study waivers or clinical study design.

トップに戻る
Powered by Translations.com GlobalLink OneLink Software